TRANSCRIPTIONAL ACTIVATION OF A HYBRID PROMOTER COMPOSED OF CYTOMEGALOVIRUS ENHANCER AND BETA-ACTIN BETA-GLOBIN GENE IN GLOMERULAR EPITHELIAL-CELLS IN-VIVO/
Y. Akagi et al., TRANSCRIPTIONAL ACTIVATION OF A HYBRID PROMOTER COMPOSED OF CYTOMEGALOVIRUS ENHANCER AND BETA-ACTIN BETA-GLOBIN GENE IN GLOMERULAR EPITHELIAL-CELLS IN-VIVO/, Kidney international, 51(4), 1997, pp. 1265-1269
The aim of this study was to seek a promoter, transactivated selective
ly in renal cells in vivo by using transgenic (tg) mouse technology. W
e generated two kinds of tg mouse lines carrying a green fluorescence
protein (GFP) cDNA driven either by cytomegalovirus enhancer and beta-
actin/beta-globin promoter (CX-GFP) or by elongation factor 1 alpha pr
omoter (EF-GFP), and investigated the expression of GFP in the kidney.
Microscopic examination of the renal tissues in CX-GFP-tg mice reveal
ed that GFP was expressed only in glomeruli, mainly epithelial cells,
but not in tubules, arteries and interstitium. Moreover, in situ hybri
dization demonstrated that GFP mRNA expression was localized in the gl
omerular cells. In contrast, GFP was not delectable in the kidney in a
ny of the lines of EF-GFP-tg mouse. To exclude the possible involvemen
t of the GFP cDNA as an enhancer, we constructed tg mice carrying the
CX promoter driving a human CD4 cDNA. It was confirmed that the expres
sion patterns of human CD4 in the kidney were quite similar to those o
f GFP in the kidney of CX-GFP-tg mice. These results strongly suggest
that CX promoter could be transactivated in glomerular epithelial cell
s in vivo.